Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Stone Investment
Haikou, Hainan, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Hainan Stone Investment is a Chinese investment and holding company primarily focused on the healthcare and pharmaceutical sectors. The firm operates as a strategic investment vehicle, often holding significant stakes in various life science enterprises and pharmaceutical manufacturing entities within China. It is notably associated with the broader ecosystem of Chinese pharmaceutical development, providing capital and strategic oversight to companies involved in drug production and medical technology. While not a direct drug developer itself, its portfolio and activities are deeply integrated into the Chinese healthcare industry, particularly in the Hainan region.
- Industry
- Investors
Beyond the preview
Go deeper on Hainan Stone Investment.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hainan Stone Investment.